Spirig HealthCare AG - Co-Irbesartan Spirig HC 150/12.5 mg, Filmtabletten | | 62743 | | 01 | | Co-Irbesartan Spirig HC 150/12.5 mg | | Filmtabletten | | C09DA04 | | Irbesartan und Diuretika | | 05.03.2013 | | |
| Composition | irbesartanum 150 mg, hydrochlorothiazidum 12.5 mg, lactosum monohydricum 34.16 mg, amylum pregelificatum, copovidonum K 28, carmellosum natricum conexum corresp. natrium 0.54 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, talcum, macrogolum 8000, E 171, E 172 (flavum), E 172 (rubrum), E 172 (nigrum), pro compresso obducto. | Packungsbestandteile | | Comprimés filmés | | | Principe actif | Concentr. |
---|
Hydrochlorothiazide | 12.5 mg | Irbesartan | 150 mg |
| BAG: Principe actif | Concentr. |
---|
Hydrochlorothiazide | 12.5 mg | Irbesartan | 150 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
(Flavum) | | | (Nigrum) | | | (Rubrum) | | | Amylum Pregelificatum | | | Carmellosum Natricum Conexum | | | Copovidonum K | 28 | | E 171 | | color. | E 172 | | color. | Hypromellosum | | Überzug | Lactose Monohydrate | 34.16 mg | | Macrogol | 8000 | | Magnesii Stearas | | | Pro Compresso Obducto | | | Silica Colloidalis Anhydrica | | | Talcum | | |
| |
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
---|
001 | 28 Comprimé(s) | 9.29 | 26.50 | B | LS | Oui | 002 | 98 Comprimé(s) | 29.98 | 49.00 | B | LS | Oui |
|
|